Proposed Data Collections Submitted for Public Comment and Recommendations, 17103-17104 [E6-4919]
Download as PDF
<![CDATA[
17103
Federal Register / Vol. 71, No. 65 / Wednesday, April 5, 2006 / Notices
and implementation of its 2003
Guidelines for Infection Control in
Dental Health Care Settings. These
Guidelines took an evidence-based
approach to recommending infection
control procedures, coalescing existing
guidelines developed over the past
decade with new infection control
measure recommendations supported by
research.
In releasing the Guidelines just over
two years ago, the CDC mailed more
then 400,000 copies to practicing
dentists, hygienists, dental schools and
educators, and health science libraries.
CDC also prepared a summary of the
Guidelines that was published in the
Journal of the American Dental
Association (JADA) in early 2004. At
this time, it is critical to the Dental
Unit’s dissemination plan to mount an
evaluation of the effectiveness of CDC’s
activities in moving the behavior of
practicing dentists in the direction of
increased adoption and implementation
of recommendations put forth in the
Guidelines.
CDC has contracted with the Research
Triangle Institute (RTI) and its
subcontractor, the American Dental
Association (ADA), to design and
conduct the first phase of such an
evaluation. This phase includes
conducting a mail survey to a
probability sample of 6,500 dentists
actively engaged in the private practice
of clinical dentistry in the United States.
The sample will be selected from the
ADA’s dentist Master file, the nation’s
most up-to-date and complete listing of
U.S. dentists. The Master file is
associated with extensive descriptive
information on U.S. dentists based on
returns to other ADA survey and
updating activities. Included in the
master file is information that will allow
the sample to: Be selected with equal
precision from the U.S. Census
Divisions; include over-representation
of selected specialties, i.e., oral surgery
and periodontics; identify dentists in
private practice; and weight the sample
according to selected demographic and
professional characteristics so the
results can accurately reflect all active
private practice dentists in the U.S. We
expect to achieve a response rate of at
least 70 percent, which will yield 4,550
completed questionnaires.
There are no costs to respondents
other than their time to participate in
the survey.
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
responses per
respondent
Number of
respondents
Form
Average
burden per response (in
hrs.)
Total burden
(in hours)
Dental Survey ..................................................................................................
4550
1
15/60
1138
Total ..........................................................................................................
........................
........................
........................
1138
Dated: March 30, 2006.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–4917 Filed 4–4–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–0595]
wwhite on PROD1PC61 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
VerDate Aug<31>2005
16:10 Apr 04, 2006
Jkt 208001
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Performance Evaluation Program for
Rapid HIV Testing (0920–0595)—
Revision—National Center for Health
Marketing (NCHM), Coordinating Center
for Health Information and Service
(CoCHIS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
To support our mission of improving
public health and preventing disease
through continuously improving
laboratory practices, the Model
Performance Evaluation Program
(MPEP), Division of Laboratory Systems,
Coordinating Center for Health
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Information and Service, Centers for
Disease Control and Prevention intends
to continue the currently ongoing HIV
rapid testing performance evaluation
program (HIV Rapid Testing MPEP).
This program offers external
performance evaluation (PE) for rapid
tests such as the OraQuick Rapid HIV–
1 Antibody Test, approved as a waived
test by the U.S. Food and Drug
Administration, and for other licensed
tests such as the MedMira Reveal.
Participation in PE programs is expected
to lead to improved HIV testing
performance because participants have
the opportunity to identify areas for
improvement in testing practices. This
program helps to ensure accurate testing
as a basis for development of HIV
prevention and intervention strategies.
This external quality assessment
program is made available at no cost (for
receipt of sample panels) to sites
performing rapid testing for HIV
antibodies. This program offers
laboratories/testing sites an opportunity
for:
(1) Assuring that the laboratories/
testing sites are providing accurate tests
through external quality assessment;
(2) Improving testing quality through
self-evaluation in a nonregulatory
environment;
(3) Testing well characterized samples
from a source outside the test kit
manufacturer;
E:\FR\FM\05APN1.SGM
05APN1
17104
Federal Register / Vol. 71, No. 65 / Wednesday, April 5, 2006 / Notices
(4) Discovering potential testing
problems so that laboratories/testing
sites can adjust procedures to eliminate
them;
(5) Comparing individual laboratory/
testing site results to others at a national
and international level, and
from the last OMB submission. In
addition, participants are required to
submit results twice/year after testing
mailed performance evaluation samples.
There is no cost to the respondents
other than their time.
(6) Consulting with CDC staff to
discuss testing issues.
Participants in the MPEP HIV Rapid
Testing program are required to
complete a laboratory practices
questionnaire survey annually. This
questionnaire has a number of changes
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form
Frequency of
responses
Average
burden per
response
Total burden
hours
HIV Rapid Testing Questionnaire ....................................................................
HIV Rapid Testing Results Booklet .................................................................
750
750
1
2
20/60
10/60
250
250
Total ..........................................................................................................
........................
........................
........................
500
Dated: March 29, 2006.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–4919 Filed 4–4–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Development
and Testing of New Medications for the
Treatment of Emerging Infectious
Diseases, Request for Applications
(RFA) Number CI06–006
wwhite on PROD1PC61 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Development and Testing of
New Medications for the Treatment of
Emerging Infectious Diseases, RFA Number
CI06–006.
Time and Date: 12 p.m.–4 p.m., April 25,
2006 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to: Development and Testing of
New Medications for the Treatment of
Emerging Infectious Diseases, RFA Number
CI06–006.
For Further Information Contact: Christine
Morrison, PhD, Scientific Review
Administrator, Office of Public Health
Research, Centers for Disease Control and
VerDate Aug<31>2005
18:34 Apr 04, 2006
Jkt 208001
Prevention, 1600 Clifton Road, NE., Mailstop
D–72, Atlanta, GA 30333, Telephone 404–
639–3098.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 30, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–4932 Filed 4–4–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10066]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
AGENCY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
The notices is being published based
on the settlement agreement in
Weichardt v. Thompson (Weichardt).
Publication of this notice in the Federal
Register will occur simultaneously with
publication of the proposed regulation
CMS–4105–P, that is also based on the
Weichardt v. Thompson (Weichardt)
agreement.
1. Type of Information Collection
Request: New Collection.
Title of Information Collection:
Medicare and Medicare Advantage
Programs; Notification Procedures for
Hospital Discharges—Generic Notice of
Hospital Non-Coverage—Detailed
Explanation of Hospital Non-Coverage.
Use: Under 42 CFR 405.1205,
405.1206, 422.620, and 422.622,
hospitals and Medicare Advantage plans
must deliver to beneficiaries and
enrollees who are receiving inpatient
hospital services, advance notice of
discharge on the day before discharge. If
the beneficiary chooses to dispute the
discharge, the beneficiary is entitled to
an expedited determination by a Quality
Improvement Organization (QIO) about
whether the provider’s coverage
decision is correct. Upon request for an
expedited review of the discharge
decision, hospitals and Medicare
Advantage plans must deliver detailed
notices to the QIO and beneficiaries/
enrollees.
Form Number: CMS–10066 (OMB#:
0938–New).
Frequency: Other: Distribution.
Affected Public: Individuals or
Households, Business or other for-profit,
Not-for-profit institutions and Federal,
State, Local or Tribal Government.
Number of Respondents: 6057.
Total Annual Responses: 12,750,000.
Total Annual Hours: 1,461,498.
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 71, Number 65 (Wednesday, April 5, 2006)]
[Notices]
[Pages 17103-17104]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-06-0595]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Performance Evaluation Program for Rapid HIV Testing (0920-0595)--
Revision--National Center for Health Marketing (NCHM), Coordinating
Center for Health Information and Service (CoCHIS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
To support our mission of improving public health and preventing
disease through continuously improving laboratory practices, the Model
Performance Evaluation Program (MPEP), Division of Laboratory Systems,
Coordinating Center for Health Information and Service, Centers for
Disease Control and Prevention intends to continue the currently
ongoing HIV rapid testing performance evaluation program (HIV Rapid
Testing MPEP). This program offers external performance evaluation (PE)
for rapid tests such as the OraQuick[supreg] Rapid HIV-1 Antibody Test,
approved as a waived test by the U.S. Food and Drug Administration, and
for other licensed tests such as the MedMira Reveal[supreg].
Participation in PE programs is expected to lead to improved HIV
testing performance because participants have the opportunity to
identify areas for improvement in testing practices. This program helps
to ensure accurate testing as a basis for development of HIV prevention
and intervention strategies.
This external quality assessment program is made available at no
cost (for receipt of sample panels) to sites performing rapid testing
for HIV antibodies. This program offers laboratories/testing sites an
opportunity for:
(1) Assuring that the laboratories/testing sites are providing
accurate tests through external quality assessment;
(2) Improving testing quality through self-evaluation in a
nonregulatory environment;
(3) Testing well characterized samples from a source outside the
test kit manufacturer;
[[Page 17104]]
(4) Discovering potential testing problems so that laboratories/
testing sites can adjust procedures to eliminate them;
(5) Comparing individual laboratory/testing site results to others
at a national and international level, and
(6) Consulting with CDC staff to discuss testing issues.
Participants in the MPEP HIV Rapid Testing program are required to
complete a laboratory practices questionnaire survey annually. This
questionnaire has a number of changes from the last OMB submission. In
addition, participants are required to submit results twice/year after
testing mailed performance evaluation samples. There is no cost to the
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Form Number of Frequency of burden per Total burden
respondents responses response hours
----------------------------------------------------------------------------------------------------------------
HIV Rapid Testing Questionnaire................. 750 1 20/60 250
HIV Rapid Testing Results Booklet............... 750 2 10/60 250
---------------------------------------------------------------
Total....................................... .............. .............. .............. 500
----------------------------------------------------------------------------------------------------------------
Dated: March 29, 2006.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-4919 Filed 4-4-06; 8:45 am]
BILLING CODE 4163-18-P
